Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Diseases × sonidegib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Basal Cell Nevus Syndrome 2 Skin Neoplasms 1 Pancreatic Diseases 1 Multiple Myeloma 1 Medulloblastoma 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Basal Cell 1 Carcinoma 1

Interventions

sonidegib 1 Sunitinib 1 Gemcitabine 1 Ascorbic Acid 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01431794 2020-01-22

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Terminated

23 enrolled 10 charts

Gastrointestinal

Carcinoma, Pancreatic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡